Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 676

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future

Ingelman-Sundberg, Magnus·2004·Trends in Pharmacological Sciences
DOI 10.1016/j.tips.2004.02.007
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tips.2004.02.007

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 18

  1. Van Schaik, 2003, CYP3A4, CYP3A5 and MDR-1 variant alleles in the Dutch Caucasian population, Clin. Pharmacol. Ther., 73, 42, 10.1016/S0009-9236(03)90510-8 · doi:10.1016/s0009-9236(03)90510-8
  2. Snyder, 1932, Studies on human inheritance. IX. The inheritance of taste deficiency in man, Ohio J. Sci., 32, 436
  3. Eichelbaum, M. et al. (1978) A probably genetic defect in the metabolism of sparteine. In Biological Oxidation of Nitrogen (Gorrow, J.W., ed), pp. 113–118, Elsevier.
  4. Dayer, 1982, Defective hydroxylation of bufuralol associated with side-effects of the drug in poor metabolisers, Eur. J. Drug Metab. Pharmacokinet., 7, 73, 10.1007/BF03189547 · doi:10.1007/bf03189547
  5. Lou, 1987, Low frequency of slow debrisoquine hydroxylation in a native Chinese population, Lancet, 2, 852
  6. Yue, 1989, Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese, Lancet, 2, 870, 10.1016/S0140-6736(89)93041-9 · doi:10.1016/s0140-6736(89)93041-9
  7. Mura, 1991, Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese, Br. J. Clin. Pharmacol., 32, 135, 10.1111/j.1365-2125.1991.tb05629.x · doi:10.1111/j.1365-2125.1991.tb05629.x
  8. Agundez, 1994, Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations, Clin. Pharmacol. Ther., 55, 412, 10.1038/clpt.1994.50 · doi:10.1038/clpt.1994.50
  9. Küpfer, 1979, Family study of a genetically determined deficiency of mephenytoin hydroxylation to p-hydroxymephenytoin in man, Pharmacologist, 21, 173
  10. Relling, 1990, Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily, J. Pharmacol. Exp. Ther., 252, 442
  11. Yamano, 1989, cDNA and deduced amino acid sequences of human P450 IIA3 (CYP2A3), Nucleic Acids Res., 17, 4888, 10.1093/nar/17.12.4888 · doi:10.1093/nar/17.12.4888
  12. Dickson, 2003, Genetics of response to proton pump inhibitor therapy, Am. J. Pharmacogenomics, 3, 303, 10.2165/00129785-200303050-00002 · doi:10.2165/00129785-200303050-00002
  13. Takahashi, 2003, Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin, Pharmacogenomics J., 3, 202, 10.1038/sj.tpj.6500182 · doi:10.1038/sj.tpj.6500182
  14. Hallberg, 2002, The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan left ventricular hypertrophy investigation vs Atenolol (SILVHIA) trial, J. Hypertens., 20, 2089, 10.1097/00004872-200210000-00030 · doi:10.1097/00004872-200210000-00030
  15. Barclay, 2003, Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status, Pharmacogenetics, 13, 627, 10.1097/00008571-200310000-00006 · doi:10.1097/00008571-200310000-00006
  16. Dalen, 1977, Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine, Ther. Drug Monit., 19, 543, 10.1097/00007691-199710000-00011 · doi:10.1097/00007691-199710000-00011
  17. de Leon, 2003, Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers, J. Clin. Psychopharmacol., 23, 420, 10.1097/01.jcp.0000085421.74359.60 · doi:10.1097/01.jcp.0000085421.74359.60
  18. Lesko, 2003, Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop, J. Clin. Pharmacol., 43, 342, 10.1177/0091270003252244 · doi:10.1177/0091270003252244

Cited by

See all 676

Metadata

Authors
Ingelman-Sundberg, M.
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2004-04
Volume
25
Issue
4
Pages
193-200
ISSN
0165-6147 (ISSN-L)
DOI
10.1016/j.tips.2004.02.007
OpenAlex
W2164705071
Cited by
676
References
66
FWCI
3.52
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.